Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Cancer Biomarkers : Section a of Disease Markers
|
June 9, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma
Fumou Sun, Yan Cheng, Catherine Ma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 4, 2011
A multicenter evaluation of tests for diagnosis of histoplasmosis
Chadi A Hage, Julie A Ribes, Nancy L Wengenack, et al.
Blood Advances
|
February 14, 2025
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry
Sheila K Pierson, Joshua D Brandstadter, Drew A Torigian, et al.
Blood Advances
|
December 6, 2019
Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias
Ashwin Sridharan, Carolina D Schinke, George Georgiev, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Cancer Biomarkers : Section a of Disease Markers
|
June 9, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma
Fumou Sun, Yan Cheng, Catherine Ma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 4, 2011
A multicenter evaluation of tests for diagnosis of histoplasmosis
Chadi A Hage, Julie A Ribes, Nancy L Wengenack, et al.
Blood Advances
|
February 14, 2025
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry
Sheila K Pierson, Joshua D Brandstadter, Drew A Torigian, et al.
Blood Advances
|
December 6, 2019
Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias
Ashwin Sridharan, Carolina D Schinke, George Georgiev, et al.
Page
of 4